Financial support from the Japan Society for the promotion of Science (Grant-in-Aid for Creative Scientific Research no.17GS0420 and 18550155) is acknowledged. We thank Dr. Yukishige Ito (Riken), Dr. Yukio Nishina (Yokohama City University), Yuri Hatakeyama, Kyoko Isumi, Ai Himeno (Otsuka Chemical Co.), and Ayako Kajihara for technical support and encouragement.
Communication
Design and Synthesis of a Homogeneous Erythropoietin Analogue with Two Human Complex-Type Sialyloligosaccharides: Combined Use of Chemical and Bacterial Protein Expression Methods†
Article first published online: 1 OCT 2009
DOI: 10.1002/anie.200904376
Copyright © 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Additional Information
How to Cite
Hirano, K., Macmillan, D., Tezuka, K., Tsuji, T. and Kajihara, Y. (2009), Design and Synthesis of a Homogeneous Erythropoietin Analogue with Two Human Complex-Type Sialyloligosaccharides: Combined Use of Chemical and Bacterial Protein Expression Methods. Angew. Chem. Int. Ed., 48: 9557–9560. doi: 10.1002/anie.200904376
- †
Publication History
- Issue published online: 30 NOV 2009
- Article first published online: 1 OCT 2009
- Manuscript Received: 5 AUG 2009
Funded by
- Japan Society for the promotion of Science. Grant Numbers: 17GS0420, 18550155
Keywords:
- erythropoietin;
- glycopeptides;
- glycoproteins;
- native chemical ligation;
- protein expression

Highly expressive: Cell proliferation was observed with concentrations of an erythropoietin (EPO) analogue above 50 pg mL−1. The EPO analogue has two human complex-type sialyloligosaccharides (see picture) and was formed by the combined use of chemical synthesis and protein expression in E. coli. Both the 24- and 30-positions are glycosylated, but the two sialyloligosaccharides do not interfere with binding of the EPO analogue to a receptor.

1521-3773/asset/2002_left.gif?v=1&s=ac6b0d94a94d7ce7a210002b8096b42feffc0bcf)
1521-3773/asset/2002_right.gif?v=1&s=451042aa3415ae3ad0729984d26dee1866aca82e)
